Refine your search
157 trials found
All(157)
Recruiting(122)
Not yet recruiting(35)
Recruiting
NCT05253651
A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer
Colorectal Neoplasms
Male or Female
18+ years
227study location(s)
Recruiting
NCT06821061
A Study to Learn About How the Flu and COVID-19 Vaccines Act in Healthy People
Influenza, COVID-19 (Coronavirus Disease 2019)
Male or Female
18+ years
26study location(s)
Recruiting
NCT05156398
Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects
Migraine
Male or Female
6 - 17 years
158study location(s)
Recruiting
NCT06629779
A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.
Metastatic Castration-Resistant Prostate Cancer
Males
18+ years
210study location(s)
Recruiting
NCT05355701
A Study to Learn About the Study Medicine Called PF-07799933 in People With Advanced Solid Tumors With BRAF Alterations.
Melanoma, Non-Small-Cell Lung Cancer, Thyroid Cancer, Glioma
Male or Female
16+ years
76study location(s)
Recruiting
NCT06215118
A Study to Learn About the Effects of the Combination of Elranatamab (PF-06863135) and Iberdomide in Patients With Relapsed or Refractory Multiple Myeloma (MagnetisMM-30)
Multiple Myeloma
Male or Female
18+ years
60study location(s)
Recruiting
NCT05090566
MagnetisMM-4: Umbrella Study of Elranatamab (PF-06863135) in Combination With Anti-Cancer Treatments in Multiple Myeloma
Multiple Myeloma
Male or Female
18+ years
58study location(s)
Recruiting
NCT06152575
MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)
Multiple Myeloma
Male or Female
18+ years
274study location(s)
Recruiting
NCT04624230
Evaluation of Oral Tofacitinib in Children Aged 2 to 17 Years Old Suffering From Moderate to Severe Ulcerative Colitis
Ulcerative Colitis
Male or Female
2 - 17 years
182study location(s)
Recruiting
NCT06679140
A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease
COVID-19 SARS-CoV-2 Infection
Male or Female
12+ years
53study location(s)
Saved trials
Saved trials
You currently don’t have any saved trials. To save a trial, select the bookmark icon on the result listing.
All(157)
Recruiting(122)
Not yet recruiting(35)
Contact us
For more information about participation in a Pfizer clinical trial, please email or call the Pfizer Clinical Trial Contact Center at 1-800-887-7002.